---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-011991"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:00:55.632624+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma issues third debenture for $2.5M, completing $5M Yorkville facility

## Summary
- On June 17, 2025, issued third debenture to YA II PN, Ltd. for $2.5M principal, net proceeds $2.25M.
- Total aggregate principal from three debentures now $5M; net proceeds to Company $4.5M.
- Debentures bear 8% annual interest (18% upon default), mature February 2, 2026, guaranteed by subsidiaries.

## SEC filing metadata
- accession: 0001062993-25-011991
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325011991/0001062993-25-011991-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325011991/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-011991
- JSON: https://secwatch.observer/filing/0001062993-25-011991.json
- Plain text: https://secwatch.observer/filing/0001062993-25-011991.txt

## Key facts
- Debt Financings
  Medicus Pharma Ltd. incurred credit facility of $2,500,000 with YA II PN, Ltd. at 8.00% per annum, subject to a potential increase to 18.00% per annum upon the oc maturing February 2, 2026.
  - Instrument: credit facility
  - Principal: $2,500,000
  - Counterparty: YA II PN, Ltd.
  - Rate: 8.00% per annum, subject to a potential increase to 18.00% per annum upon the oc
  - Maturity: February 2, 2026
  - Event: incurrence
  source text: On June 17, 2025, Yorkville purchased and the Company issued a third Debenture in aggregate principal amount of $2,500,000, such amount being the remaining amount available pursuant to the Purchase Agreement, for net proceeds to the Company of $2,250,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299325011991/0001062993-25-011991-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.